US tech earnings disappointed with guidance cautious, causing rotation into defensive Australian sectors. RBA officials remained patient with rate settings as inflation data remained within target bands. AUD/USD dipped to 0.6780 on broader USD strength and US Treasury yield increases.

MPL recovered after security concerns resolved with strong operational momentum in health insurance. Member growth accelerated in private categories with pricing power improving. At $3.45, the dividend renewal and earnings upgrade expectations offer recovery opportunity.

SHL climbed steadily as pathology demand remained robust and pricing power held firm. The company's US operations benefited from healthcare volume growth trends. At $41.20, defensive healthcare exposure with dividend growth profile suits risk-averse portfolios.

S32 gained 3% on stabilizing commodity prices and positive production updates. Diversified mining exposure to zinc, copper, and nickel provides broad commodity exposure. Near $3.80, the turnaround story with capital discipline appeals to value investors.

Spring market transitions toward end-of-season patterns with increased price negotiation from buyers. Quality properties continue to command premiums while lower-end stock faces headwinds.

This is a free edition of The Wealth Signal. Upgrade to Signal+ or Signal Pro for full analysis, entry prices, and Greg's model portfolio.